OCT eye imaging for rare retinal and choroid diseases
Part of Eyes & vision, Heart & circulation clinical trials.
This trial studies rare diseases affecting the retina or choroid using detailed eye scans (OCT). It may help doctors better understand how these conditions look in the eye and how imaging findings relate to vision.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosed retinal or choroid (eye back layer) disease
- You can give informed consent and complete all study tests within 30 days
- Your blood pressure is not dangerously high (over 180/110), or it can be lowered with treatment
- You do not have serious kidney problems like dialysis or a kidney transplant
- You can keep your eye steady for the scan and get clear images (not blocked by things like severe cataract)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures blood flow in the eye in people with acute or chronic central serous chorioretinopathy (CSC). It uses eye scans and special imaging to better understand what’s happening and whether it may differ between short-term and long-term disease.
This study uses a special type of eye scan (OCTA) to look at blood vessels in the back of the eye. It's for people with various eye conditions, and aims to help doctors see and understand these diseases better.
This trial uses a special camera (OCT) to capture detailed images of the eye. It aims to improve eye disease detection. You may join if you have retinal disease, glaucoma, corneal disease, or healthy eyes.
This study uses a special eye scan to look at the back of the eye in people with central serous chorioretinopathy (CSC). It aims to better understand the condition and may help guide future treatments.
This study uses a special imaging test (OCT angiography) to look at blood flow around the optic nerve in people with advanced glaucoma. It aims to better understand how glaucoma affects eye circulation, which may help improve future care.
This study uses a detailed eye scan (optical coherence tomography angiography) to look at how blood vessels in the retina are affected. It may help researchers better understand retinal vascular diseases, though some people will be excluded for safety or image-quality reasons.
Hear when a new Polypoidal Choroidal Vasculopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.